Ranitidine products recalled because of a nitrosamine impurity
Critical priority
What you should do
- 1Talk to your doctor or pharmacist at your earliest convenience about alternative, non-ranitidine treatment options appropriate for your health circumstances.
- 2There are many prescription and over-the-counter drug alternatives in Canada that are authorized for the same or similar uses as ranitidine.
- 3Individuals taking a prescription ranitidine drug, including a recalled product, should not stop taking it unless they have spoken to their health care provider and obtained alternative treatment, as the risk of not treating the condition may be greater than the risk related to NDMA exposure.
- 4Contact your health care provider if you have taken a ranitidine product and you have concerns about your health.
- 5Report any health product adverse events or complaints to Health Canada.
The issue
Product safety
Affected product
Over-the-counter and prescription ranitidine drugs (LATEST UPDATE: March 11, 2022 – Pharmascience Inc. recall)
Where it was sold
Canada (national)Reported in the official notice — confirm there.
Issued by
Health Canada
Read the official Government of Canada notice
All recallsRecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.